PEGylated miRNA-LUC liposomes
| 【Numbering】BKNM-L21 | 【CAS】cas | ||
| 【Item No.】BKNM-L21-03 | 【specification】 | ||
|
|||
Item No.: BKNM-L21
Packing specification: 1ml / 5ml / 10ml
Particle size control: 110~145nm
Average potential: ~ +20 mV
Polydispersity coefficient: ≤ 0.2
Basic application: genetic drug delivery for scientific research
Extended application: targeted gene therapy technology
Main components: cationic lipid material, PEGylated lipid, miRNA (GenePharma)
Preparation method: thin film dispersion method
Encapsulation factor: targeting luciferase gene miRNA
Storage conditions: 4℃ low temperature
Life cycle: 6-12 months
Sterilization method: filter sterilization
Message
Packing specification: 1ml / 5ml / 10ml
Particle size control: 110~145nm
Average potential: ~ +20 mV
Polydispersity coefficient: ≤ 0.2
Basic application: genetic drug delivery for scientific research
Extended application: targeted gene therapy technology
Main components: cationic lipid material, PEGylated lipid, miRNA (GenePharma)
Preparation method: thin film dispersion method
Encapsulation factor: targeting luciferase gene miRNA
Storage conditions: 4℃ low temperature
Life cycle: 6-12 months
Sterilization method: filter sterilization
Usage: cell administration; animal intravenous injection
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |
Previous： the end...
Next： PE immunotoxin nanopar
